TransAct Technologies Incorporated TACT
4.87
(0.04)
(0.81%)
as of 25 Sep
- Market cap
- $50.7M
- P/E
- 0.0×
Follow TACT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.13 | 0.63 | 0.78 | 1.09 | |
P/FCF ratio |
34.24 | 7.09 | 6.66 | 6.84 | |
P/Operating CF |
27.88 | (35.40) | 66.25 | 15.08 | |
P/B ratio |
1.84 | 1.04 | 1.30 | 1.72 | |
Price to Tangible BV |
2.26 | 1.21 | 1.49 | 1.97 | |
EV/Sales |
0.79 | 0.30 | 0.41 | 0.71 | |
EV/EBITDA |
209.38 | 557.49 | 0.00 | 0.00 | |
EV/Operating CF |
7.65 | 2.27 | 2.72 | 3.78 | |
EV/FCF |
23.74 | 3.30 | 3.45 | 4.46 | |
Quick Ratio |
1.94 | 2.25 | 2.05 | 2.02 | |
Current Ratio |
2.65 | 3.13 | 2.97 | 3.05 | |
Net Debt/EBITDA |
(230.80) | (20.28) | 20.62 | (113.23) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.11 | 1.15 | 1.16 | 1.05 | |
Operating CF/Net income |
(43.10) | (1.23) | (0.54) | 242.00 | |
Capex/Depreciation |
(11.23) | (3.54) | (1.04) | (8.66) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
8.79% | 9.57% | 14.71% | 12.57% | |
Selling, General and Administrative Expense of Revenue |
41.80% | 35.39% | 42.95% | 37.08% | |
Intangible Assets out of Total Assets |
0.12 | 0.10 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
3.26% | 3.54% | 4.38% | 4.00% | |
Graham Net Nets |
0.37 | 0.69 | 0.62 | 0.47 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.57%) | (1.30%) | (3.02%) | (14.77%) | |
Free Cash Flow Yield |
2.92% | 14.11% | 15.02% | 14.61% | |
Revenue per Share |
1.36 | 1.42 | 1.14 | 1.30 | |
Operating CF per Share |
0.21 | (0.09) | 0.06 | 0.36 | |
Capex per Share |
(0.15) | (0.05) | (0.02) | (0.14) | |
Free Cash Flow per Share |
0.06 | (0.15) | 0.04 | 0.22 | |
Cash per Share |
1.88 | 1.85 | 2.03 | 1.98 | |
Shareholders Equity per Share |
3.18 | 3.17 | 3.08 | 3.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.18 | 3.17 | 3.08 | 3.15 | |
Free Cash Flow |
0.61 | (1.51) | 0.44 | 2.22 | |
Working Capital |
25.27 | 26.34 | 25.76 | 26.33 | |
Capital Expenditures |
(1.55) | (0.56) | (0.17) | (1.41) | |
Net Current Asset Value |
22.22 | 23.11 | 25.16 | 25.95 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.11 | 0.04 | 0.01 | 0.11 | |
Net Profit Margin |
(0.36%) | 5.31% | (9.88%) | 0.11% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
9.08 | 9.04 | 6.44 | 6.63 | |
Average Payables |
4.48 | 4.54 | 4.05 | 3.46 | |
Average Inventory |
11.03 | 11.99 | 13.51 | 14.29 | |
Average Assets |
47.79 | 46.03 | 44.40 | 47.74 | |
Average Common Equity |
31.98 | 31.61 | 30.87 | 35.07 |
Columns are period end dates